Portal de Periódicos da CAPES

Carta Acesso aberto Produção Nacional Revisado por pares

BIBTEX RIS

Curcumin as a potential treatment for COVID ‐19

2020; Wiley; Volume: 34; Issue: 9 Linguagem: Romeno

10.1002/ptr.6745

1099-1573

Francisco Airton Castro Rocha, Marcos Renato de Assis,

Nigella sativa pharmacological applications

Phytotherapy ResearchVolume 34, Issue 9 p. 2085-2087 LETTER TO THE EDITOR Curcumin as a potential treatment for COVID-19 Francisco Airton Castro Rocha, Corresponding Author Francisco Airton Castro Rocha [email protected] orcid.org/0000-0003-4370-3294 Department of Internal Medicine, Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, Brazil Correspondence Francisco Airton Castro Rocha, Laboratório de Investigação em Osteoartropatias, Instituto de Biomedicina, Rua Cel. Nunes de Melo, 1315-1°, Andar, Rodolfo Teófilo, 60430-270, Fortaleza, CE, Brazil. Email: [email protected]Search for more papers by this authorMarcos Renato de Assis, Marcos Renato de Assis orcid.org/0000-0002-6567-4570 Department of Internal Medicine, Faculdade de Medicina de Marília (FAMEMA), Marília, Brazil Department of Rheumatology, Faculdade de Medicina de Assis (FEMA), Assis, BrazilSearch for more papers by this author Francisco Airton Castro Rocha, Corresponding Author Francisco Airton Castro Rocha [email protected] orcid.org/0000-0003-4370-3294 Department of Internal Medicine, Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, Brazil Correspondence Francisco Airton Castro Rocha, Laboratório de Investigação em Osteoartropatias, Instituto de Biomedicina, Rua Cel. Nunes de Melo, 1315-1°, Andar, Rodolfo Teófilo, 60430-270, Fortaleza, CE, Brazil. Email: [email protected]Search for more papers by this authorMarcos Renato de Assis, Marcos Renato de Assis orcid.org/0000-0002-6567-4570 Department of Internal Medicine, Faculdade de Medicina de Marília (FAMEMA), Marília, Brazil Department of Rheumatology, Faculdade de Medicina de Assis (FEMA), Assis, BrazilSearch for more papers by this author First published: 22 May 2020 https://doi.org/10.1002/ptr.6745Citations: 27Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookxLinkedInRedditWechat No abstract is available for this article. REFERENCES Aggarwal, B. B., Gupta, S. C., & Sung, B. (2013). Curcumin: An orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. British Journal of Pharmacology, 169, 1672–1692. 10.1111/bph.12131 CASPubMedWeb of Science®Google Scholar Akinyemi, A. J., Thome, G. J., Morsch, V. M., Stefanello, N., Goularte, J. F., Belló-Klein, A., … Schetinger, M. R. C. (2015). Effect of dietary supplementation of ginger and turmeric rhizomes on angiotensin-1 converting enzyme (ACE) and arginase activities in L-NAME induced hypertensive rats. Journal of Functional Foods, 17, 792–801. https://doi.org/10.1016/j.jff.2015.06.011 10.1016/j.jff.2015.06.011 CASWeb of Science®Google Scholar Fazal, Y., Fatima, S. N., Shahid, S. M., & Mahboob, T. (2015). Effects of curcumin on angiotensin-converting enzyme gene expression, oxidative stress, and antioxidant status in thioacetamide-induced hepatotoxicity. Journal of the Renin-Angiotensin-Aldosterone System, 16, 1046–1051. https://doi.org/10.1177/1470320314545777 10.1177/1470320314545777 CASPubMedWeb of Science®Google Scholar Heinrich, M., Appendino, G., Efferth, T., Fürst, R., Izzo, A. A., Kayser, O., … Viljoen, A. (2020). Best practice in research - Overcoming common challenges in phytopharmacological research. Journal of Ethnopharmacology, 246, 112230. https://doi.org/10.1016/j.jep.2019.112230 Epub 2019 Sep 14. 10.1016/j.jep.2019.112230 CASPubMedWeb of Science®Google Scholar Lelli, D., Sahebkar, A., Johnston, T. P., & Pedone, C. (2017). Curcumin use in pulmonary diseases: State of the art and future perspectives. Pharmacological Research, 115, 133–148. https://doi.org/10.1016/j.phrs.2016.11.017 Epub 2016 Nov 22. 10.1016/j.phrs.2016.11.017 CASPubMedWeb of Science®Google Scholar Mounce, B. C., Cesaro, T., Carrau, L., Vallet, T., & Vignuzzi, M. (2017). Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding. Antiviral Research, 142, 148–157. https://doi.org/10.1016/j.antiviral.2017.03.014 10.1016/j.antiviral.2017.03.014 CASPubMedWeb of Science®Google Scholar Pagano, E., Romano, B., Izzo, A. A., & Borrelli, F. (2018). The clinical efficacy of curcumin-containing nutraceuticals: An overview of systematic reviews. Pharmacological Research, 134, 79–91. https://doi.org/10.1016/j.phrs.2018.06.007 10.1016/j.phrs.2018.06.007 CASPubMedWeb of Science®Google Scholar Pang, X. F., Zhang, L. H., Bai, F., Wang, N. P., Garner, R. E., McKallip, R. J., & Zhao, Z. Q. (2015). Attenuation of myocardial fibrosis with curcumin is mediated by modulating expression of angiotensin II AT1/AT2 receptors and ACE2 in rats. Drug Design, Development and Therapy, 11(9), 6043–6054. https://doi.org/10.2147/DDDT.S95333 Google Scholar Prasad, S., & Tyagi, A. K. (2015). Curcumin and its analogues: A potential natural compound against HIV infection and AIDS. Food & Function, 6, 3412–3419. https://doi.org/10.1039/c5fo00485c 10.1039/C5FO00485C CASPubMedWeb of Science®Google Scholar Vaduganathan, M., Vardeny, O., Michel, T., McMurray, J. J. V., Pfeffer, M. A., & Solomon, S. D. (2020). Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. The New England Journal of Medicine, 382, 1653–1659. https://doi.org/10.1056/NEJMsr2005760 10.1056/NEJMsr2005760 CASPubMedWeb of Science®Google Scholar Wichmann, D., Sperhake, J. P., Lütgehetmann, M., Steurer, S., Edler, C., Heinemann, A., … Kluge, S. (2020). Autopsy findings and venous thromboembolism in patients with COVID-19: A prospective cohort study. Annals of Internal Medicine. https://doi.org/10.7326/M20-2003. [Epub ahead of print]. 10.7326/M20-2003 PubMedWeb of Science®Google Scholar Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C. L., Abiona, O., … McLellan, J. S. (2020). Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science, 367, 1260–1263. 10.1126/science.abb2507 CASPubMedWeb of Science®Google Scholar Citing Literature Volume34, Issue9September 2020Pages 2085-2087 This article also appears in:The Pharmacological Potential of Plant Compounds and Preparations in COVID-19 ReferencesRelatedInformation